Alberti KG - Search Results

1

Effects of self monitoring of triglyceride concentrations in non-insulin dependent diabetes.

Stewart MW, Laker MF, Alberti KG. Stewart MW, et al. Among authors: alberti kg. BMJ. 1993 Feb 20;306(6876):493. doi: 10.1136/bmj.306.6876.493. BMJ. 1993. PMID: 8448460 Free PMC article. Clinical Trial. No abstract available.

2

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.

Farrer M, Winocour PH, Evans K, Neil HA, Laker MF, Kesteven P, Alberti KG. Farrer M, et al. Among authors: alberti kg. Diabetes Res Clin Pract. 1994 Mar;23(2):111-9. doi: 10.1016/0168-8227(94)90018-3. Diabetes Res Clin Pract. 1994. PMID: 8070302 Clinical Trial.

3

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.

Farrer M, Game FL, Albers CJ, Neil HA, Winocour PH, Laker MF, Adams PC, Alberti KG. Farrer M, et al. Among authors: alberti kg. BMJ. 1993 Oct 2;307(6908):832-6. doi: 10.1136/bmj.307.6908.832. BMJ. 1993. PMID: 8401124 Free PMC article.

4

Self-monitoring of triglycerides by type 2 diabetic patients: variability in fasting and postprandial levels.

Stewart MW, Albers C, Laker MF, Hattemer A, Alberti KG. Stewart MW, et al. Among authors: alberti kg. Diabet Med. 1996 Oct;13(10):894-7. doi: 10.1002/(SICI)1096-9136(199610)13:10<894::AID-DIA264>3.0.CO;2-4. Diabet Med. 1996. PMID: 8911784

5

Effect of bezafibrate on metabolic profiles in non-insulin-dependent diabetes mellitus.

Alberti KG, Jones IR, Laker MF, Swai AB, Taylor R. Alberti KG, et al. J Cardiovasc Pharmacol. 1990;16 Suppl 9:S21-4; discussion S24-5. J Cardiovasc Pharmacol. 1990. PMID: 1710741 Clinical Trial.

6

Relation of lipid peroxides to macrovascular disease in type 2 diabetes.

Velázquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Velázquez E, et al. Among authors: alberti kg. Diabet Med. 1991 Oct;8(8):752-8. doi: 10.1111/j.1464-5491.1991.tb01695.x. Diabet Med. 1991. PMID: 1838067

7

Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus.

Snowden C, Houlston RS, Arif MH, Laker MF, Humphries SE, Alberti KG. Snowden C, et al. Among authors: alberti kg. Clin Chim Acta. 1991 Jan 31;196(1):49-57. doi: 10.1016/0009-8981(91)90207-s. Clin Chim Acta. 1991. PMID: 2022058

8

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM.

Jones IR, Swai A, Taylor R, Miller M, Laker MF, Alberti KG. Jones IR, et al. Among authors: alberti kg. Diabetes Care. 1990 Aug;13(8):855-63. doi: 10.2337/diacare.13.8.855. Diabetes Care. 1990. PMID: 2209320 Clinical Trial.

9

Within-clinic reagent strip lipid measurement.

Neil HA, Cassidy DM, Laker MF, Alberti KG. Neil HA, et al. Among authors: alberti kg. Diabet Med. 1989 Dec;6(9):824-8. doi: 10.1111/j.1464-5491.1989.tb01289.x. Diabet Med. 1989. PMID: 2533047

10

Features of syndrome X in first-degree relatives of NIDDM patients.

Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M. Stewart MW, et al. Among authors: alberti kg. Diabetes Care. 1995 Jul;18(7):1020-2. doi: 10.2337/diacare.18.7.1020. Diabetes Care. 1995. PMID: 7555535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters